Press Releases

Wednesday, September 14, 2011
ConjuChem Initiates Phase 2 Study of Diabetes Drug
Tuesday, August 30, 2011
ConjuChem Resumes Operations Led by Dr. Patrick Soon-Shiong
Monday, June 8, 2009
ConjuChem Reports Data on PC-DAC(TM):Exendin-4 and PC-Insulin at 2009 American Diabetes Association Meeting
Monday, February 9, 2009
ConjuChem reports final data confirming PC-DAC(TM):Exendin-4 lowers glucose and weight in Phase II diabetes trials
Wednesday, December 3, 2008
ConjuChem’s PC-DAC(TM):Exendin-4 Lowers Glucose and Weight in Phase II Diabetes Trials
Wednesday, November 5, 2008
ConjuChem Provides Development Update
Wednesday, February 20, 2008
ConjuChem Initiates Phase II Study of PC-DAC(TM):Exendin-4
Wednesday, October 17, 2007
ConjuChem Reports Final Results of PC-DAC(TM): Exendin-4 Phase I/II Multiple-Dose Study for Type 2 Diabetes Confirming Safety and Efficacy at Once-Weekly Dosing
Tuesday, June 19, 2007
ConjuChem Biotechnologies Reports PC-DAC(TM):Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
Monday, March 26, 2007
PC-DAC(TM):Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results Demonstrate Safety and Efficacy at Once-Weekly Dosing
 
  • About Us
  • Technology
  • Pipeline
  • News
  • Partnering

News

  • Events
© ConjuChem, LLC. All Rights Reserved    
  • Terms Of Use
Website design: Hane Chow Inc.